Evolving role of anti-VEGF for diabetic macular oedema: from clinical trials to real life

Eye (Lond). 2020 Mar;34(3):415-417. doi: 10.1038/s41433-019-0590-0. Epub 2019 Sep 20.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / drug therapy
  • Humans
  • Macular Edema* / drug therapy

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab